| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/28/2004 | EP1383505A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 01/28/2004 | EP1181335B1 Extended rhodamine compounds useful as fluorescent labels |
| 01/28/2004 | CN1136226C Synthesis and anticancer activity of conjugated phospholipid compounds |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/27/2004 | US6683173 Tm leveling methods |
| 01/27/2004 | US6683166 Modified internucleoside linkages (ii) |
| 01/27/2004 | US6683061 Enzyme catalyzed therapeutic activation |
| 01/27/2004 | US6683060 Chelating zinc with 1-(3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine -2,4(1h,3h)-dione; ovarian cancer |
| 01/27/2004 | US6683045 Nucleosides for imaging and treatment applications |
| 01/27/2004 | US6682887 Snp detection sequences bound to target dna are partially degraded with release of said electrophoretic tag, each released product produced from a given detection sequence has a known, unique electrophoretic mobility |
| 01/27/2004 | US6682715 Nucleosides for imaging and treatment applications |
| 01/22/2004 | WO2004007773A1 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 01/22/2004 | WO2004007751A2 Nucleic acid labeling methods |
| 01/22/2004 | WO2004007519A1 Partial and full agonists of a1 adenosine receptors |
| 01/22/2004 | WO2004007512A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/22/2004 | WO2004006940A1 Medicinal composition for drug-induced neuropathy |
| 01/22/2004 | WO2004006887A2 Composition and methods for the treatment of skin disorders |
| 01/22/2004 | WO2003050248A3 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 01/22/2004 | US20040014959 Synthesis of locked nucleic acid derivatives |
| 01/22/2004 | US20040014957 Useful as antisense agents, ribozymes, aptamers, probes/primers, or as substrate for ribonucleases when hybridized to RNA |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014711 Cytidine diphosphate choline ester |
| 01/22/2004 | US20040014710 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 01/22/2004 | US20040014696 Using blocking agent which is removal with enzyme |
| 01/22/2004 | US20040014076 Method for sequencing nucleic acid sequences without chain termination |
| 01/22/2004 | US20040014042 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
| 01/22/2004 | CA2492725A1 Medicinal composition for drug-induced neuropathy |
| 01/22/2004 | CA2492248A1 Composition and methods for the treatment of skin disorders |
| 01/22/2004 | CA2492212A1 Nucleic acid labeling methods |
| 01/22/2004 | CA2490666A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/21/2004 | EP1381698A2 Method for analysing nucleic acid chains |
| 01/21/2004 | EP1165584B1 2'-substituted rna preparation |
| 01/20/2004 | US6680382 Coupling adenine derivative with blocked arabinofuranosyl derivative to form 2-chloro-9-(2'-deoxy-2'-fluoro-b-arabinofuranosyl)adenine; anticancer agents; viricides |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | US6680292 Pharmaceutical composition comprising ribavirin and growth factors and methods of use |
| 01/20/2004 | CA2116782C 1-substituted 1h-imidazo¬4,5-c|quinolin-4-amines; intermediate and pharmaceutical compositions |
| 01/20/2004 | CA2110335C Process for producing n4-acyl-5'-deoxy-5-fluorocytidine derivatives |
| 01/15/2004 | WO2004005259A1 Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound |
| 01/15/2004 | WO2003045966A3 Nucleoside analog libraries |
| 01/15/2004 | US20040009933 Fluorescent nitrogenous base and nucleosides incorporating same |
| 01/15/2004 | US20040009239 Use of anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies |
| 01/14/2004 | EP1379536A1 Building blocks for the solution phase synthesis of oligonucleotides |
| 01/14/2004 | EP1274704B1 Process for preparing 5'-acetylstavudine |
| 01/14/2004 | EP0832091B1 C-4' modified adenosine kinase inhibitors |
| 01/14/2004 | CN1468249A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/14/2004 | CN1467216A Method for purifying protected 2'-deoxycytidines |
| 01/13/2004 | US6677450 N12, n13-bridged sugar derivatives of indolylopyrrolocarbazoles, useful in inhibiting the proliferation of tumor cells |
| 01/13/2004 | US6677345 Cyclin dependent kinase inhibitors |
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6677315 Nucleosides for imaging and treatment applications |
| 01/13/2004 | US6677314 Nucleosides for imaging and treatment applications |
| 01/13/2004 | US6677310 Ring-expanded nucleosides and nucleotides |
| 01/13/2004 | US6677120 Building blocks for the solution phase synthesis of oligonucleotides |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004003210A2 Selective functionalization of hydrocarbons with isolated oxygenases and mediator based regeneration |
| 01/08/2004 | WO2004003138A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/08/2004 | WO2004003002A1 Novel adenosine analogues and their use as pharmaceutical agents |
| 01/08/2004 | WO2004003001A1 Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates |
| 01/08/2004 | WO2004003000A2 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections |
| 01/08/2004 | WO2004002999A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 01/08/2004 | WO2004002508A1 Particles by facile ligand exchange reactions |
| 01/08/2004 | WO2004002422A2 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | US20040006176 Nucleoside analog libraries |
| 01/08/2004 | US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
| 01/08/2004 | US20040006002 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 01/08/2004 | CA2490253A1 Novel adenosine analogues and their use as pharmaceutical agents |
| 01/08/2004 | CA2489552A1 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | CA2488484A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1465583A 8-chloro-adenosine analogs, compositions containing said compound and use thereof |
| 01/07/2004 | CN1133642C Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 01/07/2004 | CN1133641C Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparation process |
| 01/07/2004 | CN1133640C 3'-azido-deoxythymidine-5'-thiopyhosphamino acid ester compound and its preparing process |
| 01/06/2004 | US6673940 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 01/06/2004 | US6673779 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages |
| 01/06/2004 | US6673775 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/06/2004 | US6673550 Probes for use in the detection and measurement of preferential compound in sample |
| 01/02/2004 | EP1375671A1 Selective functionalization of hydrocarbons with isolated oxygenases and mediator-based regeneration |
| 01/02/2004 | EP1375508A1 N6-substituted adenosine analogues and their use as pharmaceutical agents |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373552A2 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 01/02/2004 | EP1373288A1 Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides |
| 01/02/2004 | EP1373286A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 01/02/2004 | EP0986570B9 Gemcitabine derivatives |
| 01/01/2004 | US20040002596 1,2,4-triazole triazole nucleosides; used to treat an infection, an infestation, a neoplasm, or an autoimmune disease |
| 01/01/2004 | US20040002595 Nucleic acid labeling compounds |
| 01/01/2004 | US20040002476 Modified fluorinated nucleoside analogues |
| 01/01/2004 | US20040002475 Antiviral compounds |
| 12/31/2003 | WO2004000858A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/31/2003 | WO2002078747A9 Pregabalin lactose conjugates |
| 12/31/2003 | CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/30/2003 | US6670342 Method of treating hepatitis delta virus infection |
| 12/30/2003 | US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone |
| 12/30/2003 | US6670336 Aryl phosphate derivatives of d4T having anti-HIV activity |
| 12/30/2003 | CA2102241C Use of macrolide compounds for eye diseases |
| 12/25/2003 | US20030236397 Process for preparing beta-L-2'deoxy-thymidine |